Icon
+91 94997 68112
Login Register

Trijardy XR - (5mg/2.5mg/1 g,10mg/5mg/1g,12.5mg/5mg/1g,25mg/5mg/1)

Empagliflozin, Linagliptan and Metformin Hydrochloride Boehringer Ingelheim
5mg/2.5mg/1 g,10mg/5mg/1g,12.5mg/5mg/1g,25mg/5mg/1
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
TRIJARDY XR is a combination of empagliflozin, linagliptin, and metformin hydrochloride (HCl) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Yes
*** ****** ** ***. *** ****** ***** * **** ** ** ******* ’***, ’***, ’***, ’***, ’***, ’***, ’***, ’*** *** ***** ** '*** *** *** *********. ** ****** **** **** *** ****** ** *** ****. ********* **** ***** ** ***** **, ****.
Trijardy XR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12 Patent 13 Patent 14 Patent 15 Patent 16
*** ****** *** ********* *** ********* **** ** *** **, **** *** ********* *** ********* *** ********* **** ** *** **, **** *** ********* **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, ****
***** *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* **** ** *** **, **** *** ********* **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** **** ** ***** **, **** *** ********* **** ** *** **, ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** ****** ***\ ********* *** **, **** ******* **** *** ****** *** ****
***** **\ ** *** **, **** ******* **** *** ****** *** ****
  1. *** **, **** : *** ****** ******** ********** ********* ***** **'* **** ** ****** ** ******* ’***, ’***, ’***, ’***, ’***, ’***, ’***, *** ’***
  2. *** **, **** : ********** ***** * **** ******* *** ****** ** ****** ’***, ’***, ’***, ’***, ’***, ’***, ’***, *** ’***
  3. *** **, **** : ********** ***** * **** ******* *** ****** ** ****** ’***
  4. *** **, **** : ********** **** ** *****
  5. *** **, **** : ****** ******** ******** ** ***** **, **** *** ******.
  6. *** **, **** : ********** **** ***** *** *** ****** ** * ***** ****** ****** '*** ******** ** ***** **, ****.
  7. *** *, **** : ***** *** ********* ********. ***** ** *** *********. ** ******, **** ***** **** ***** **** ***.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.